	Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer. Pharmacoecon Open Wu YS, Burger EA, Holmboe F, Bangum M, Oteiza F, Bugge C, Sæther EM, Aas E. PMID: 42315785 [PubMed - as supplied by publisher]
	Correlative assessment of p53 immunostaining patterns andÂ TP53 mutation status by next-generation sequencing inÂ lung adenocarcinoma (LUAD). Histopathology Zhang Y, Zheng K, Tang Y, Yang K, Chen Z, Li Y, Zhang Y, Zhang G, Qiu L, Peng R, Liu X, Jiang L. PMID: 42315496 [PubMed - as supplied by publisher]
	Journey Mapping of the Patient Experience from Diagnosis to End of Life in Lung Cancer: A Qualitative Meta-Synthesis. Semin Oncol Nurs Zhang F, Wang Y, Xiao Y, Li J, Liu Y, Li H, Wang Z, Li W. PMID: 42315410 [PubMed - as supplied by publisher]
	Mitochondrial DNA in Lung Cancer: from biology to clinical implications. Crit Rev Oncol Hematol Lucio-Lozada J, Prada D, Beato-González L, Hirsch FR, Cardona AF, Hernández-Pedro N, Arrieta O. PMID: 42314881 [PubMed - as supplied by publisher]
	Prospective study of proton beam therapy for non-small cell lung cancer patients with idiopathic pulmonary fibrosis. Radiother Oncol Shin H, Yang K, Yoo H, Park HY, Shin SH, Noh JM, Pyo H. PMID: 42314836 [PubMed - as supplied by publisher]
	Off-Protocol Radiotherapy in Prospective Systemic Therapy Trials for Metastatic Non-Small Cell Lung Cancer. Clin Lung Cancer Ruicci KM, Li GJ, Warner A, Youssef A, Parmar A, Mutsaers A, Palma DA, Louie AV. PMID: 42314501 [PubMed - as supplied by publisher]
	Corrigendum to "POU2F3 in Small Cell Lung Cancer (SCLC): Diagnostic Utility in Neuroendocrine-Low/Negative SCLC and Discrimination From Other Thoracic Malignancies and Other Small Blue Round Cell Tumors" [Laboratory Investigation 2026;106(6):106124]. Lab Invest Chen X, Zou F, Xu H, Zhang Z, Wang J, Li Y, Jia J, Sun S, Wang C, Zhang J. PMID: 42314383 [PubMed - as supplied by publisher]
	Mapping the evidence of stereotactic body radiotherapy combined with systemic therapy in oligometastatic and oligoprogressive non-small cell lung cancer: A visual synthesis of clinical outcomes and toxicity. Cancer Treat Res Commun Karagiannis V, Tolia M, Vomvas D, Mazonakis M, Shiarli AM, Saarinen J, Nåhls NS, Ntaskagiannis D, Morfo G, Jekunen A. PMID: 42314262 [PubMed - as supplied by publisher]
	Optimized Simultaneous N/O-Glycopeptide Enrichment Strategy Identifies Lung Cancer Diagnostic Biomarkers in Serum. J Proteome Res Zhou Z, Zhao J, Zhang J, Wu P, Yang Y, Li W, Peng C, Qiang Z. PMID: 42313501 [PubMed - as supplied by publisher]
	An overview of circular RNAs in the regulation of autophagy in lung cancer. Discov Oncol Rejili M, Abass KS, Hashemi F. PMID: 42313297 [PubMed - as supplied by publisher]
	Cisplatin versus carboplatin as adjuvant chemotherapy for completely resected non-small cell lung cancer: a multicenter retrospective cohort study. Surg Today Hamaji M, Miyata R, Takeuchi J, Ozu N, Kohama T, Sumitomo R, Takahashi M, Fukada T, Kobayashi M, Kumaya Y, Chen-Yoshikawa TF. PMID: 42313168 [PubMed - as supplied by publisher]
	First-Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK-Positive Non-Small Cell Lung Cancer with Brain Metastases: A Real-World Multicenter Study from Vietnam. Thorac Cancer Nguyen HG, Nguyen XH, Nguyen P, Nguyen TH, Vinh QB. PMID: 42313051 [PubMed - indexed for MEDLINE]
	Impact of local treatment on survival outcomes in patients with metastatic lung cancer with oligoprogression undergoing immunotherapy. Swiss Med Wkly Domenach B, Mismetti V, Bouleftour W, Bareille A, Tiffet O, Desage AL, Fournel P. PMID: 42312985 [PubMed - indexed for MEDLINE]
	Review Article \| Diagnosis and Early Detection of Lung Cancer: Present and Future Approaches. Gulf J Oncolog Fadelelmoula T. PMID: 42312823 [PubMed - indexed for MEDLINE]
	Unveiling the cognitive fog in lung cancer patients: non-invasive exploration of blood-brain barrier disruption and brain structural changes. Ann Med Zhang DF, Ma H, Zhang ZP, Ai J, Cao WT, Li ZH. PMID: 42312599 [PubMed - indexed for MEDLINE]
	RTsDEN: reverse task attention enabled deep learning model for lung cancer detection using computed tomography. Expert Rev Anticancer Ther Sundara Raj Retna Bai L, Joseph A, Sundara Raj Retna Bai F. PMID: 42312470 [PubMed - as supplied by publisher]
	Complete Response in Metastatic Rectal Cancer with Hepatic and Pulmonary Metastases Treated with Second-Line FOLFIRI plus Ramucirumab: A Case Report. Case Rep Oncol Hasegawa M, Okayama H, Kitabori Y, Yamauchi N, Nakajima T, Matsumoto S, Sato N, Saito M, Kono K. PMID: 42312106 [PubMed]
	A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma. MedComm (2020) Hu M, Liu S, Han Y, Wang F, Liu Y, Lu B, Li H, Gao Y, Wang Y, Yang W, Shi K, Xiao B, Wang Q, Du J, Lin H, Li X, Wang C, Zhang T. PMID: 42311860 [PubMed]
	Risk prediction models for postoperative atrial fibrillation in patients with lung cancer: a systematic review and meta-analysis. Front Cardiovasc Med Yang F, Sun T, Shang Y, Chen Y, Wu J, Shang X. PMID: 42311770 [PubMed]
	Current status and trends of immune-related adverse events in lung cancer treated with immune checkpoint inhibitors: a bibliometric analysis of the past decade (2016-2025). Front Immunol Guo B, Zhang G, Sang S, Ma X, Qi H. PMID: 42311664 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 160601

Page 1 of 8031



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy